Myeloproliferative neoplasms trials in Netherlands
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- Where
- Amsterdam, Utrecht
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07357727EU 2025-523555-66-00Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- Where
- Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 426 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07623200EU 2026-525398-38-00Registry updated 2026-11-05
Phase 1/2RecruitingTrial-stage medicine
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Where
- Maastricht
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04176198EU 2022-502597-16-00Registry updated 2026-10-02
Phase 2RecruitingResearch participation
A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor-naïve myelofibrosis and moderate thrombocytopenia.
- Where
- Hoofddorp
- Age
- 18 years and over
- People
- 38 worldwide
- Run by
- Karyopharm Therapeutics Inc.
See details and how to join2024-511309-47-00EU 2024-511309-47-00Registry updated 2026-09-25
Phase 2RecruitingTrial-stage medicine
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Groningen
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875EU 2024-511407-42-00Registry updated 2026-09-15
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060Registry updated 2026-07-01
Phase 3RecruitingTrial-stage medicine
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
- Where
- Dordrecht, Enschede, Hoofddorp
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT06093672EU 2022-502276-23-00Registry updated 2026-03-25
Phase 2RecruitingTrial-stage medicine
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Where
- Hoofddorp
- Age
- 18 years and over
- People
- 58 worldwide
- Run by
- Karyopharm Therapeutics Inc
See details and how to joinNCT05980806Registry updated 2026-02-12
Phase 3RecruitingResearch participation
An extension study for patients previously enrolled in studies with pelabresib
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 34 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT06401356EU 2023-508950-24-00Registry updated 2026-01-28
Phase 2Not yet recruitingResearch participation
RuxoTam; A phase II study to evaluate safety and efficacy of tamoxifen in combination with Ruxolitinib in patients with myelofibrosis
- Where
- Groningen
- Age
- 18 years and over
- People
- 14
- Run by
- Universitair Medisch Centrum Groningen
See details and how to join2024-510926-19-00EU 2024-510926-19-00Registry updated 2025-11-11
Phase 1/2RecruitingTrial-stage medicine
Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition
- Where
- Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT06605586EU 2024-511565-11-00Registry updated 2025-03-07
No phaseRecruitingResearch participation
Effect of Phlebotomy on Heartrate in Polycythemia Patients
- Where
- Leiden
- Age
- 18 years and over
- People
- 10
- Run by
- Leiden University Medical Center
See details and how to joinNCT05396170Registry updated 2024-11-13
All Myeloproliferative neoplasms trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.